Medaffcon Explored Transportability of Evidence Between Finland and the United States
When local evidence is insufficient to support decision-making, research findings and real-world evidence generated elsewhere may help fill the gap.
The study ‘Migraine comorbidity and phenotypic disease networks in occupational health care’ was presented in the 19th Congress of the International Headache Society in Dublin, Ireland (5-8 September, 2019). The objective of this new RWE study was to further elucidate the migraine burden by examining the ICD-10 coded phenotypic diseasomes for migraine patients. This study was conducted together with Novartis and Terveystalo. You can access the abstract from the link below.
Abstract of Migraine comorbidity and phenotypic disease networks in occupational health care

Migraine comorbidity and phenotypic disease networks in occupational health care. Korolainen M A, Kurki S, Tuominen S, Toppila I, Lassenius M I, Santaholma J, Purmonen T, Nissilä M. 19th Congress of the International Headache Society, Sep 7-8, 2019; Dublin, Ireland.
When local evidence is insufficient to support decision-making, research findings and real-world evidence generated elsewhere may help fill the gap.
Finland is currently developing a national assessment and decision-making model for medicines.
Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.